Medicare prescription drug benefits : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, first session, June 11, 1991

LDR 01622nam a2200421 a 4500
001 003475320
003 MiAaHDL
005 20130211000000.0
006 m d
007 cr bn ---auaua
008 000424s1992 dcua b f000 0 eng c
010 ‡a92187341
020 ‡a0160372909
035 ‡a(MiU)003475320
035 ‡asdr-miu003475320
035 ‡asdr-pst.a1623963
035 ‡a(OCoLC)25569212
040 ‡aDGPO/DLC ‡cDLC ‡dGPO ‡dEYM
043 ‡an-us---
050 0 0 ‡aKF27 ‡b.W344 1991l
074 ‡a1028-A, 1028-B (MF)
082 0 0 ‡a368.4/26/00973 ‡220
086 0 ‡aY 4.W 36:102-39
110 1 ‡aUnited States. ‡bCongress. ‡bHouse. ‡bCommittee on Ways and Means. ‡bSubcommittee on Health.
245 1 0 ‡aMedicare prescription drug benefits : ‡bhearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
260 ‡aWashington : ‡bU.S. G.P.O. : ‡bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, ‡c1992.
300 ‡aiii, 89 p. : ‡bill. ; ‡c24 cm.
500 ‡a"Serial 102-39."
500 ‡aShipping list no.: 92-143-P.
500 ‡aDistributed to some depository libraries in microfiche.
500 ‡aItem 1028-A, 1028-B (MF)
504 ‡aIncludes bibliographical references.
538 ‡aMode of access: Internet.
650 2 ‡aMedicare.
650 2 ‡aDrug Costs.
650 2 ‡aInsurance, Pharmaceutical Services ‡zUnited States.
650 0 ‡aMedicare.
650 0 ‡aPrescription pricing ‡zUnited States.
650 0 ‡aDrugs ‡xPrices ‡zUnited States.
650 0 ‡aPharmaceutical services insurance ‡zUnited States.
CID ‡a003475320
DAT 0 ‡a20130211152448.0 ‡b20130211000000.0
DAT 1 ‡a20130215185024.0 ‡b2019-10-19T18:22:04Z
CAT ‡aSDR-MIU ‡dEX LIBRIS - ALEPH ‡lloader.pl-002-002
FMT ‡aBK
HOL ‡0sdr-miu003475320 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015042696362 ‡sMIU ‡1003475320
974 ‡bMIU ‡cMIU ‡d20191019 ‡sgoogle ‡umdp.39015042696362 ‡y1992 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bPST ‡cPST ‡d20180116 ‡sgoogle ‡upst.000019267357 ‡z4.W 36:102-39 ‡y1992 ‡rpd ‡qbib ‡tUS fed doc